2-(3-Oxo-1,3-diphenylpropyl)cyclohexan-1-one, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine, 95.0%, 1g

Sample tub Type 2117, 1000 ml, 4 Piece(s)

4-(4-Fluorophenoxy)piperidine hydrochloride, 95.0%, 1g

4-((Chloromethyl)sulfonyl)morpholine, 95.0%, 100mg

Silicone oil M 3, 1 l

6-Bromo-1-methyl-1H-pyrazolo[4,3-b]pyridine, 95.0%, 1g

2-Methyl-3,5-dinitroaniline, 97.0%, 1g

tert-butyl 4-amino-4-(trifluoromethyl)piperidine-1-carboxylate, 95.0%, 100mg

N-(4-Acetylphenyl)methanesulfonamide, 95.0%, 10g

6-Methylimidazo[1,2-b]pyridazine-3-carboxylic acid, 97%, 100mg

N-Methylsaccharin>98.0%(GC)5g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate, 95.0%, 5g